Grail’s multicancer early detection (MCED) blood test, Galleri, is being made available to Fountain Health Insurance customers at 100% coverage, the firms announced on Tuesday.
In a clinical study, the Galleri test demonstrated that it detects a shared signal from more than 50 types of cancers. More than 45 of them currently lack recommended screening tests, the firms noted.
Using advanced genomics and machine learning, the test also determines the origin of the cancer signal, which can then guide a diagnostic workup.
